SCHEMBL5453589

SCHEMBL5453589

COc1ccc(C)cc1NC(=O)Nc1ccc(C2=CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.57
MAPT P10636 6/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
TP53 P04637 2/20 0.53
GAA P10253 1/20 0.53
MAPK1 P28482 1/20 0.53
ALDH1A1 P00352 2/20 0.52
CASP3 P42574 2/20 0.51
SENP7 Q9BQF6 2/20 0.51
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
RAB9A P51151 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SENP6 Q9GZR1 1/20 0.48
GRM5 P41594 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458325 0.89 NAMPT (0.64) NAMPTMAPTMEN1KMT2ATP53
SCHEMBL5460061 0.88 MAPT (0.60) NAMPTMAPTMEN1KMT2ATP53
SCHEMBL5473484 0.84 NAMPT (0.62) NAMPTALDH1A1GRM5GRM1CDK7
SCHEMBL5455872 0.82 MAPT (0.56) NAMPTMAPTMEN1KMT2ATP53
SCHEMBL5458426 0.81 CASP3 (0.64) MAPTMEN1KMT2ATP53GAA
SCHEMBL5459789 0.80 NAMPT (0.56) NAMPTMAPTMEN1KMT2ATP53
SCHEMBL5465684 0.80 NAMPT (0.65) NAMPTMAPTMEN1KMT2AALDH1A1
SCHEMBL19103495 0.80 GRM1 (0.55) NAMPTGRM5GRM1CDK7CDK13
SCHEMBL23411537 0.80 QDPR (0.59) NAMPTGRM5GRM1CDK7CDK13
SCHEMBL29891552 0.80 QDPR (0.59) NAMPTGRM5GRM1CDK7CDK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885MAPT 758/4885MEN1 1828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.